Technology transfer of reporter VN assay
Ended Definitive Contract Awarded Last action
- Contract number
- W911QY21C0012
- Awardee
-
Microbiologics, Inc. UEI KEMMK7KX5VM5
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $2,195,778
Award facts
- Opportunity
-
- Program Announcement: JPEO-CBRND & BARDA Commercial Solutions Opening (CSO) Special Notice · W911QY20SC001 · Posted Jun 18, 2020
- Medical Countermeasures (MCM) Commercial Solutions Opening (CSO) Solicitation · Posted Jun 29, 2020
- Contract value 16% obligated
-
- $2,195,778.34 Current, with exercised options
- $13,593,328.34 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Two Step
- Pricing
- Firm Fixed Price
- Place of performance
- St Cloud, MN 56303, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$457,633 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $1,637,447 | |
| Original award | $1,015,964 |
About this award
This definitive contract from the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (JPEO-CBRND) awards Microbiologics, Inc. $13.6 million to deliver technology transfer of reporter VN assay in support of advanced SARS-CoV-2 medical countermeasure therapeutics. The solicitation sought proposals to manufacture and fill-finish a minimum of 100,000 treatment courses by March 2021 to treat the indicated U.S. population, with candidate therapeutics demonstrating capability for Emergency Use Authorization or FDA approval by end of 2020. The firm fixed-price contract runs from November 2020 through December 2022 for performance in St. Cloud, Minnesota and supports JPEO-CBRND and Biomedical Advanced Research and Development Authority's Commercial Solutions Opening solicitation to strengthen the U.S. medical response against COVID-19. There is no set-aside designation for this award to Microbiologics, Inc. for reporter VN assay technology transfer.
Quick answers
Who was awarded contract W911QY21C0012?
W911QY21C0012 was awarded to Microbiologics, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on November 9, 2020.
How much is contract W911QY21C0012 worth?
The government has obligated $2,195,778 on W911QY21C0012. Its potential value, with all options, is $13,593,328.
Which agency awarded contract W911QY21C0012?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY21C0012, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY21C0012 competed?
The extent of competition for W911QY21C0012 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award